212 related articles for article (PubMed ID: 15592902)
21. Anti-lactoferrin antibodies in patients with connective tissue diseases.
Manolova IM
Folia Med (Plovdiv); 2003; 45(4):25-30. PubMed ID: 15272812
[TBL] [Abstract][Full Text] [Related]
22. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
23. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus.
Spronk PE; Bootsma H; Horst G; Huitema MG; Limburg PC; Tervaert JW; Kallenberg CG
Br J Rheumatol; 1996 Jul; 35(7):625-31. PubMed ID: 8670594
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of antineutrophil cytoplasmic autoantibodies with specificity for lactoferrin in renal diseases.
Sinico RA; Pozzi C; Radice A; Tincani A; Li Vecchi M; Rota S; Comotti C; Ferrario F; D'Amico G
Am J Kidney Dis; 1993 Aug; 22(2):253-60. PubMed ID: 8352249
[TBL] [Abstract][Full Text] [Related]
25. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
[TBL] [Abstract][Full Text] [Related]
26. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis.
Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J
Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764
[TBL] [Abstract][Full Text] [Related]
27. Clinical implications of antineutrophil cytoplasmic antibody test in lupus nephritis.
Chin HJ; Ahn C; Lim CS; Chung HK; Lee JG; Song YW; Lee HS; Han JS; Kim S; Lee JS
Am J Nephrol; 2000; 20(1):57-63. PubMed ID: 10644870
[TBL] [Abstract][Full Text] [Related]
28. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Danowski A; Kickler TS; Petri M
J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
[TBL] [Abstract][Full Text] [Related]
29. Distribution of IgG subclass anti-nuclear antibodies (ANAs) in systemic lupus erythematosus.
Zeng Y; Zhang Y; Chen Q; Huang Q; Lin Y; Wang X; Wang JJ; Jiang L; Xiao Y
Lupus; 2021 May; 30(6):901-912. PubMed ID: 33622075
[TBL] [Abstract][Full Text] [Related]
30. Antibodies in systemic lupus antineutrophil cytoplasmic erythematosus: prevalence, disease activity correlations and organ system associations.
Fauzi AR; Kong NC; Chua MK; Jeyabalan V; Idris MN; Azizah R
Med J Malaysia; 2004 Aug; 59(3):372-7. PubMed ID: 15727383
[TBL] [Abstract][Full Text] [Related]
31. [Anti-myeloperoxidase and anti-lactoferrin antibodies in patients with IgA nephropathy and Henoch-Schönlein purpura].
Nishiya K; Chikazawa H; Matsumori A; Chijiwa T; Tahara K; Morita T; Hosokawa T; Ito H; Hashimoto K; Fujieda M
Rinsho Byori; 1999 Feb; 47(2):185-7. PubMed ID: 10097638
[TBL] [Abstract][Full Text] [Related]
32. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations.
Ong SG; Cheng HM; Soon SC; Goh E; Chow SK; Yeap SS
Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986
[TBL] [Abstract][Full Text] [Related]
33. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Prevalence, specificities, and clinical significance.
Schnabel A; Csernok E; Isenberg DA; Mrowka C; Gross WL
Arthritis Rheum; 1995 May; 38(5):633-7. PubMed ID: 7748219
[TBL] [Abstract][Full Text] [Related]
34. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
35. Assessment of anti-nucleosome antibody (ANuA) isotypes for the diagnosis and prediction of systemic lupus erythematosus and lupus nephritis activity.
Zeng Y; Xiao Y; Zeng F; Jiang L; Yan S; Wang X; Lin Q; Yu L; Lu X; Zhang Y; Lin Y
Clin Exp Med; 2023 Sep; 23(5):1677-1689. PubMed ID: 36385418
[TBL] [Abstract][Full Text] [Related]
36. Antibodies to thromboplastin in systemic lupus erythematosus: isotype distribution and clinical significance in a series of 92 patients.
Font J; López-Soto A; Cervera R; Casals FJ; Reverter JC; Muñoz FJ; Miret C; Bové A; Ordinas A; Ingelmo M
Thromb Res; 1997 Apr; 86(1):37-48. PubMed ID: 9172285
[TBL] [Abstract][Full Text] [Related]
37. Anticardiolipin and anti-beta2glycoprotein-I antibodies in patients with systemic lupus erythematosus: comparison between Colombians and Spaniards.
Cucurull E; Espinoza LR; Mendez E; Molina JF; Molina J; Ordi-Ros J; Gharavi AE
Lupus; 1999; 8(2):134-41. PubMed ID: 10192508
[TBL] [Abstract][Full Text] [Related]
38. IgG subclass distribution of anticardiolipin antibody in patients with systemic lupus erythematosus.
Tsutsumi A; Koike T; Ichikawa K; Shimada K; Takabayashi K; Tomioka H; Yoshida S
J Rheumatol; 1988 Dec; 15(12):1764-7. PubMed ID: 3265958
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus.
Cabral AR; Cabiedes J; Alarcón-Segovia D
Lupus; 2004; 13(3):182-7. PubMed ID: 15119547
[TBL] [Abstract][Full Text] [Related]
40. [The prediction of thrombosis development in patients with systemic lupus erythematosus: the role of antibodies to cardiolipin].
Nasonov EL; Kovalev VIu; Alekberova ZS; Solov'ev SK
Ter Arkh; 1992; 64(5):25-30. PubMed ID: 1455369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
